Question 1

What is Bill C-286?

Accepted Answer

Bill C-286 is a Other.

Question 2

How often does Bill C-286 appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Bill C-286 first tracked by Ergen?

Accepted Answer

First tracked on Jun 16, 2026.

Question 4

When was Bill C-286 last mentioned in news?

Accepted Answer

Last active on Jun 16, 2026.

Question 5

What is Bill C-286's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Bill C-286 in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Bill C-286?

Accepted Answer

Canada Bill C-286 Psilocybin Access (Jun 16, 2026, 6 articles).

Question 8

How did the "Canada Bill C-286 Psilocybin Access" event impact Bill C-286?

Accepted Answer

Bill C-286 is a private member's bill aimed at amending the Controlled Drugs and Substances Act and the Food and Drugs Act to facilitate medical access to psilocybin and psilocin, which is central to this event.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.